Ida Contasta
About
Ida Contasta is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine.
According to data from OpenAlex, Ida Contasta has authored 25 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 11 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Ida Contasta's work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Ida Contasta is often cited by papers focused on Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Ida Contasta collaborates with scholars based in Italy. Ida Contasta's co-authors include Patrizia Pellegrini, Anna Maria Berghella, Domenico Adorno, Tiziana Del Beato, Rocco Totaro, Antonio Carolei, Carlo Umberto Casciani, A. Canossi, D. Adorno and A Piazza and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Translational Medicine and Cancer Immunology Immunotherapy.
In The Last Decade
Ida Contasta
25 papers receiving 345 citations
Peers
Ida Contasta
C. Ewel United States
Xuzhang Lu China
Shanjuan Hong China
Malte Roerden Germany
Supinya Iamsawat United States
Vitalijs Ovcinnikovs United Kingdom
Manop Pithukpakorn Thailand
Lonnette Diggs United States
Nicoletta Arduino Italy
Ding‐Ping Chen Taiwan
Citations per year, relative to Ida Contasta Ida Contasta (= 1×)
peers
C. Ewel
Countries citing papers authored by Ida Contasta
Since
Specialization
Citations
This map shows the geographic impact of Ida Contasta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ida Contasta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ida Contasta more than expected).
Fields of papers citing papers by Ida Contasta
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ida Contasta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ida Contasta. The network helps show where Ida Contasta may publish in the future.
Co-authorship network of co-authors of Ida Contasta
This figure shows the co-authorship network connecting the top 25 collaborators of Ida Contasta. A scholar is included among the top collaborators of Ida Contasta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ida Contasta. Ida Contasta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Berghella, Anna Maria, et al.. (2017). The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender- specific Biomarkers in Personalized Cancer Therapy. Current Drug Targets. 18(4). 485–495.
2.
Berghella, Anna Maria, Ida Contasta, Giuseppe Marulli, et al.. (2014). Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age. Immunity & Ageing. 11(1). 3–3.
3.
Contasta, Ida, Rocco Totaro, Patrizia Pellegrini, et al.. (2012). A gender-related action of IFNbeta-therapy was found in multiple sclerosis. Journal of Translational Medicine. 10(1). 223–223.
4.
Berghella, Anna Maria, Ida Contasta, Tiziana Del Beato, & Patrizia Pellegrini. (2012). The discovery of how gender influences age immunological mechanisms in health and disease, and the identification of ageing gender-specific biomarkers, could lead to specifically tailored treatment and ultimately improve therapeutic success rates. Immunity & Ageing. 9(1). 24–24.
5.
Berghella, Anna Maria, et al.. (2011). The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy. Cancer Immunology Immunotherapy. 60(10). 1373–1381.
6.
Contasta, Ida, Rocco Totaro, Anna Maria Berghella, et al.. (2010). Soluble CD30: A Biomarker for Evaluating the Clinical Risk versus Benefit of IFNβ1A Treatment in Multiple Sclerosis Patients. International Journal of Immunopathology and Pharmacology. 23(1). 213–226.
7.
Contasta, Ida, Patrizia Pellegrini, Anna Maria Berghella, Tiziana Del Beato, & Domenico Adorno. (2006). Colon Cancer and Gene Alterations: Their Immunological Implications and Suggestions for Prognostic Indices and Improvements in Biotherapy. Cancer Biotherapy and Radiopharmaceuticals. 21(5). 488–505.
8.
Pellegrini, Patrizia, Anna Maria Berghella, Ida Contasta, Tiziana Del Beato, & Domenico Adorno. (2006). The Study of a Patient's Immune System May Prove to be a Useful Noninvasive Tool for Stage Classification in Colon Cancer. Cancer Biotherapy and Radiopharmaceuticals. 21(5). 443–467.
9.
Berghella, Anna Maria, Ida Contasta, Patrizia Pellegrini, Tiziana Del Beato, & Domenico Adorno. (2006). Are Immunological Mechanisms Involved in Colon Cancer and Are They Possible Markers for Biotherapy Improvement?. Cancer Biotherapy and Radiopharmaceuticals. 21(5). 468–487.
10.
Pellegrini, Patrizia, Rocco Totaro, Ida Contasta, et al.. (2005). CD30 Antigen and Multiple Sclerosis: CD30, an Important Costimulatory Molecule and Marker of a Regulatory Subpopulation of Dendritic Cells, Is Involved in the Maintenance of the Physiological Balance between TH1/TH2 Immune Responses and Tolerance. NeuroImmunoModulation. 12(4). 220–234.
11.
Berghella, Anna Maria, Rocco Totaro, Patrizia Pellegrini, et al.. (2005). Immunological Study of IFNβ-1a-Treated and Untreated Multiple Sclerosis Patients: Clarifying IFNβ Mechanisms and Establishing Specific Dendritic Cell Immunotherapy. NeuroImmunoModulation. 12(1). 29–44.
12.
Pellegrini, Patrizia, Rocco Totaro, Ida Contasta, et al.. (2004). IFN??-1a Treatment and Reestablishment of Th1 Regulation in MS Patients. Clinical Neuropharmacology. 27(6). 258–269.
13.
Contasta, Ida, Anna Maria Berghella, Patrizia Pellegrini, & Domenico Adorno. (2003). Passage from Normal Mucosa to Adenoma and Colon Cancer: Alteration of Normal sCD30 Mechanisms Regulating TH1/TH2 Cell Functions. Cancer Biotherapy and Radiopharmaceuticals. 18(4). 549–557.
14.
Berghella, Anna Maria, Ida Contasta, Patrizia Pellegrini, Tiziana Del Beato, & Domenico Adorno. (2002). Peripheral Blood Immunological Parameters for Use as Markers of Pre-invasive to Invasive Colorectal Cancer. Cancer Biotherapy and Radiopharmaceuticals. 17(1). 43–50.
15.
Contasta, Ida, Patrizia Pellegrini, Anna Maria Berghella, & Domenico Adorno. (2001). Cell Cycle Control in Cellular Homeostasis During the Immune Response: Interactions Between TH1, TH2 Cytokines, and Bcl2 and p53 Molecules. Cancer Biotherapy and Radiopharmaceuticals. 16(1). 63–71.
16.
Pellegrini, Patrizia, Ida Contasta, Anna Maria Berghella, et al.. (2000). The TH1 and TH2 Cytokine Network in Healthy Subjects: Suggestions for Experimental Studies to Create Prognostic and Diagnostic Indices for Biotherapeutic Treatments. Cancer Biotherapy and Radiopharmaceuticals. 15(3). 267–278.
17.
Pellegrini, Patrizia, et al.. (2000). Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer. Cancer Immunology Immunotherapy. 49(7). 388–394.
18.
Berghella, Anna Maria, Patrizia Pellegrini, Ida Contasta, Tiziana Del Beato, & Domenico Adorno. (1998). Bcl-2 and Drugs Used in the Treatment of Cancer: New Strategies of Biotherapy which should not be Underestimated. Cancer Biotherapy and Radiopharmaceuticals. 13(4). 225–237.
19.
Contasta, Ida, Patrizia Pellegrini, Anna Maria Berghella, et al.. (1997). Immunological Implications of Alterations in the c-Ki-ras and p53 Genes in the Stepwise Progression of Colorectal Cancer: Indications for the Improvement of Prognosis, Biotherapy Treatment and Tumor Biology Understanding. Cancer Biotherapy and Radiopharmaceuticals. 12(6). 385–393.
20.
Contasta, Ida, Patrizia Pellegrini, Anna Maria Berghella, et al.. (1996). Necessity of Biotherapeutic Treatments Inducing TH1 Cell Functions in Colorectal Cancer. Cancer Biotherapy and Radiopharmaceuticals. 11(6). 373–383.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by C. Ewel Breakdown of academic impact, for papers by Xuzhang Lu Breakdown of academic impact, for papers by Shanjuan Hong Breakdown of academic impact, for papers by Malte Roerden Breakdown of academic impact, for papers by Supinya Iamsawat Breakdown of academic impact, for papers by Vitalijs Ovcinnikovs Breakdown of academic impact, for papers by Manop Pithukpakorn Breakdown of academic impact, for papers by Lonnette Diggs Breakdown of academic impact, for papers by Nicoletta Arduino Breakdown of academic impact, for papers by Ding‐Ping Chen